#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cholangiocarcinoma Follicular lymphoma stage III Metastatic malignant melanoma Malignant glioma Pleural mesothelioma Plasma cell myeloma refractory Chronic cutaneous lupus erythematosus Burkitt's lymphoma Chronic hepatitis B Leukocyte adhesion deficiency type I Marginal zone lymphoma recurrent Mitochondrial myopathy Tuberous sclerosis complex Lymphoma Solitary fibrous tumour More trials…

    Learn about Rare Diseases

    Atypical haemolytic uraemic syndrome – Diagnostics Friedreich’s ataxia – Diagnostics Castleman’s disease – Diagnostics Cystic fibrosis lung – Trials in Disease Optic glioma – Treatment Paroxysmal nocturnal haemoglobinuria – Trials in Disease Mucopolysaccharidosis II – Treatment Hypereosinophilic syndrome Rhabdoid tumour – Basic Information Phenylketonuria More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cd19-Car_Lenti_Allo Pimozide D5-Ethyl-Beta-D-Glucuronide Mps-214 Nifedipine Neomycin Sulfate Cocarboxylase Tetrahydrate Ozanimod Tominersen Doxycycline Monohydrate Candesartan Cilexetil Tomligisiran GSK3862995B Tradipitant Salmeterol Xinafoate OLVEREMBATINIB Mk-1167 IHMA-2121771-1 Dextrose Bp IDOR-1117-2520C More therapies…

    Learn about Your Condition

    Brain injury Rabies Exfoliation glaucoma Arterial disorder Reperfusion injury Spinal cord injury cervical Eye inflammation High-grade B-cell lymphoma Rectal neoplasm Constipation Liposarcoma metastatic Decreased appetite Acute kidney injury Red blood cell abnormality Varicella More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Musculoskeletal Diseases

  • Study on Sarilumab and Etanercept for Rheumatoid Arthritis in Patients Not Responding to csDMARD Therapy

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Sarilumab
    • Etanercept
    Belgium Germany Italy The Netherlands Portugal Spain

  • Study on Painful Thumb Osteoarthritis: Comparing Triamcinolone Acetonide, Sodium Chloride, and Occupational Therapy for Patients with Inflammatory Thumb Joint Pain

    Recruiting

    3 1 1
    Investigated Diseases:
    • Osteoarthritis
    Investigated Drugs:
    • Sodium Chloride
    • Triamcinolone Acetonide
    Norway

  • Study on Early Oral Antibiotic Treatment for Vertebral Osteomyelitis Using Cefuroxime, Dicloxacillin, and Ceftriaxone for Adult Patients

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Osteomyelitis
    Investigated Drugs:
    • Benzylpenicillin
    • Clindamycin
    • Cloxacillin
    Denmark

  • Study on Reducing Rituximab Dosage for Patients with Rheumatoid Arthritis

    Recruiting

    3 1 1 1
    Investigated Diseases:
    • Rheumatoid arthritis
    Investigated Drugs:
    • Rituximab
    Belgium

  • Efficacy and Safety of Givinostat for Non-Ambulant Patients with Duchenne Muscular Dystrophy

    Recruiting

    3 1
    Investigated Diseases:
    • Duchenne muscular dystrophy
    Investigated Drugs:
    • Givinostat
    Belgium Czechia France Germany Italy The Netherlands +3

  • Study on the Long-term Effects of EDG-5506 for Adults and Adolescents with Becker Muscular Dystrophy

    Recruiting

    2 1 1
    Investigated Drugs:
    • Edg-5506
    Belgium Denmark France Germany Italy The Netherlands +1
Previous Page
1 … 23 24 25 26 27 … 67
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!